John Wiley & Sons (FRA:2F7) Research & Development: €0 Mil (TTM As of Apr. 2026)


FRA:2F7 John Wiley & Sons Inc FRA:2F7
56 GF Score
Price €38.20
GF Value €33.32
! 6 Warning Signs
View Full Analysis

What is John Wiley & Sons Research & Development?

John Wiley & Sons FRA:2F7 -1.55% 56 Research & Development is €0 Mil as of Apr. 2026. GuruFocus rates FRA:2F7 with a GF Score™ of 56/100 and a GF Value™ of €33.32. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. John Wiley & Sons's Research & Development for the three months ended in Apr. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 was €0 Mil.

John Wiley & Sons  (FRA:2F7) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

John Wiley & Sons Research & Development Related Terms

John Wiley & Sons Research & Development Historical Data

* Premium members only.

The historical data trend for John Wiley & Sons's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

John Wiley & Sons Research & Development Chart

John Wiley & Sons Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

John Wiley & Sons Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:2F7
56GF Score
John Wiley & Sons Inc FRA:2F7
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

John Wiley & Sons Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
John Wiley & Sons (FRA:2F7) has a Research & Development of €0 Mil as of Apr. 2026. Research and development expense is the total cost for research and development activities. View historical data on John Wiley & Sons and its competitors.
Is John Wiley & Sons' Research & Development too high?
John Wiley & Sons' current Research & Development is €0 Mil. Overall, John Wiley & Sons has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does John Wiley & Sons' Research & Development compare to TDAY and SCHL?
John Wiley & Sons' Research & Development of €0 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Media - Diversified company?
A good Research & Development depends on the Media - Diversified industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on John Wiley & Sons and its competitors. John Wiley & Sons's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is John Wiley & Sons stock overvalued right now?
John Wiley & Sons (FRA:2F7) has a current Research & Development of €0 Mil. The stock's GF Value™ is €33.32, compared to a current price of €38.20 — trading 14.6% above its estimated fair value. The current Research & Development is €0 Mil. John Wiley & Sons' overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For John Wiley & Sons (FRA:2F7), the current Research & Development is €0 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is John Wiley & Sons (FRA:2F7) Overvalued in 2026?

Based on GuruFocus' analysis, John Wiley & Sons stock appears to be overvalued. The current stock price of €38.20 is trading 14.6% above its estimated GF Value™ of €33.32.

Key valuation signals for FRA:2F7:

  • Research & Development: €0 Mil
  • GF Value™: €33.32 vs. price of €38.20 (14.6% above fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the FRA:2F7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

John Wiley & Sons Business Description

Address 111 River Street, Hoboken, NJ, USA, 07030
John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.
56GF Score

Get the complete analysis for FRA:2F7

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€38.20
Price
€33.32
GF Value